This Article Full Text Full Text (PDF) Additional Materials Correction (v28,pe150) All Versions of this Article: 28/4/718    most recent ATVBAHA.107.160713v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Lombardi, A. Articles by Luconi, M. PubMed PubMed Citation Articles by Lombardi, A. Articles by Luconi, M.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:718.)
© 2008 American Heart Association, Inc.

Cell Biology/Signaling

A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor- and Interferon- Inflammatory Effects in Human Endothelial Cells

Adriana Lombardi; Giulia Cantini; Elisabetta Piscitelli; Stefania Gelmini; Michela Francalanci; Tommaso Mello; Elisabetta Ceni; Gabriele Varano; Gianni Forti; Mario Rotondi; Andrea Galli; Mario Serio; Michaela Luconi

From the DENOthe Center of Excellence for Research, Transfer and High Education: Department of Clinical Physiopathology (A.L., G.C., E.P., S.G., M.F., T.M., E.C., G.V., G.F., M.R., A.G., M.S., M.L.), University of Florence; and the Unit of Internal Medicine and Endocrinology (M.R.), Fondazione Salvatore Maugeri I.R.C.C.S., Pavia, Italy.

Correspondence to Michaela Luconi, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. E-mail m.luconi{at}dfc.unifi.it

Abstract

Objective— Microvascular endothelium is one of the main targets of the inflammatory response. On specific activation, endothelial cells recruit Th1-lymphocytes at the inflammatory site. We investigated the intracellular signaling mediating tumor necrosis factor (TNF)- and interferon (IFN)- inflammatory response in human microvascular endothelial cells (HMEC-1) and the interfering effects of the peroxisome-proliferator-activated-receptor (PPAR) agonist, rosiglitazone (RGZ).

Methods and Results— TNF and IFN, mainly when combined, stimulate IFN-inducible protein of 10 kDa (IP10) and fractalkine production evaluated by ELISA and TaqMan analyses. This effect is not only mediated by activation of the NFkB and Stat1 classic pathways, but also involves a rapid increase in phosphorylation and activation of extracellular signal-regulated kinases (ERK1/2) as measured by Western blot. RGZ interferes with TNF and IFN stimulation of IP10, fractalkine, and adhesion molecule through a novel rapid mechanism which involves the blocking of ERK activation.

Conclusions— Our findings shed new light on the mechanisms underlying the inflammatory response of microvascular endothelium and on the possible therapeutic use of RGZ in vasculopathies involving Th1-responses.

We demonstrate that TNF and IFN proinflammatory effects, such as upregulation of IP10 secretion, fractalkine, and adhesion molecule expression, are partially prevented by RGZ in human microvascular endothelial cells through a novel rapid nongenomic mechanism involving the ability of this molecule to inhibit ERK activation/phosphorylation.

Key Words: thiazolidinediones • MAPK • CXCL10 • endothelium • Th1-response